⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | PGIM India Healthcare Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹12.10 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Anandha Padmanabhan Anjeneyan | Nikhil Mathur |
| Inception | 06 Dec 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 17.11% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 10.00% | 29.15% |
| Risk | ||
| 14.23 | 14.07 | |
| 0.58 | 0.59 | |
| 0.48 | 1.59 | |
| 11.04 | 21.67 | |
| 0.97 | 3.48 | |
| -9.20% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.96% | 1.03% |
| Exit Load | 0.50% on or before 90D, Nil after 90D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
PGIM India He…61%
HDFC MF61%
39.0%Only 39.0% of holdings by weight are common between PGIM India Healthcare Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingPGIM India Healthcare Fund - Growth - Direct PlanHDFC MF
Divi's Laboratories Ltd.10.36%9.39%
Sun Pharmaceutical Industries Ltd.10.25%8.28%
Torrent Pharmaceuticals Ltd.8.49%3.65%
Max Healthcare Institute Ltd.4.71%3.61%
Neuland Laboratories Ltd.2.91%3.24%
Aster DM Quality Care Ltd.2.56%3.56%
Rubicon Research Ltd.2.99%2.52%
Krishna Institute of Medical Sciences Ltd2.99%2.10%
Cipla Ltd.2.04%4.15%
Lupin Ltd.1.93%3.55%
Category context: Equity vs Equity. Open the full Screener →